ClinicalTrials.gg
Status unknownNCT03772301Updated Dec 11, 2018

Evaluation of Hoarding Behaviour and Eating Disorders Among Holocaust Survivors and Their Descendants

An observational study in Hoarding Disorder, sponsored by Hillel Yaffe Medical Center. Status unknown. Per ClinicalTrials.gov, last updated 2018-12-11.

Sponsored by Hillel Yaffe Medical Center · Observational

The sponsor has not verified this record recently (last verified Dec 2018), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Model
Ecologic or community
Time perspective
Prospective
Enrollment
1,000
Sex
All
01

Study summary

"Hoarding "is a common behavior among Holocaust survivors and is related to the traumatic events they have experienced, and we assume that storage behavior and eating disorders are related to future generations of Holocaust survivors.

02

Conditions studied

  • Hoarding Disorder

Browse trials for

03

In context

Hoarding Disorder

32 studies on the registry are indexed under Hoarding Disorder; 5 are open to participants now.

Browse Hoarding Disorder studies →

Lead sponsor

Hillel Yaffe Medical Center is the lead sponsor of 305 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Jewish Holocaust survivors living in Germany and Israel Their direct offspring and their children (second and third generation)

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Jewish Holocaust survivors living in Germany and Israel who have expressed their written and written consent to participate in monitoring and testing, and who are able to answer the research questionnaires.

    • Their direct offspring and their children (second and third generation)
  2. The control population - non-Jewish subjects who are not the descendants of Holocaust survivors living in Germany who have expressed their written and oral consent to participate in monitoring and testing and who are able to answer the research questionnaires and whose parents were not imprisoned in the camps second.

Exclusion criteria

Exclusion Criteria:

  • (Participants who do not agree to participate (did not sign form
  • Respondents who are unable to answer interviewer questions
  • Non-Jewish subjects whose parents were in camps (ie prisoner camps, labor camps, etc.) during the second war.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Ecologic or community
Time perspective
Prospective
Enrollment
1,000 participants (estimated)
Patient registry
No

Groups and cohorts

  • Group 1

    At least 200 Jewish Holocaust survivors of the first generation living in Germany and Israel - an equal number in each country

  • Group 2

    The second generation, whose parents lived in Europe during the Second World War, now live in Germany (originating from Western and Eastern Europe) - at least 200 participants.

  • Group 3

    Third generation of Jewish Holocaust survivors who participated in the first phase, currently living in Germany and Israel - at least 200 participants including at least 100 subjects in each country. These are adults only. The research program does not include children and adolescents

06

What researchers measure

Primary outcomes

  1. Hoarding

    Questionnaire that will follow behaviour over generations

    Time frame: Three years

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 11, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03772301
Responsible party
Sponsor
First posted
Dec 11, 2018
Start date
Jan 1, 2019 (estimated)
Primary completion
Jan 2022 (estimated)
Completion
Jan 2022 (estimated)
Last update
Dec 11, 2018

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Dec 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion